Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil–cisplatin regimen in oesophageal cancer
2017 ◽
Vol 84
◽
pp. 239-249
◽
Keyword(s):
Keyword(s):
2016 ◽
Vol 103
(12)
◽
pp. 1665-1675
◽
Keyword(s):
1996 ◽
Vol 103
(2)
◽
pp. 142-149
◽
Keyword(s):
2018 ◽
Vol 94
◽
pp. 206-215
◽
2010 ◽
Vol 56
(4)
◽
pp. 253-258
◽
Keyword(s):
2014 ◽
Vol 18
(9)
◽
pp. 2098-2105
◽
Keyword(s):
Keyword(s):